BioSpace News Archive

Espyr today is launching REALYZE, an innovative behavioral health solution that packs a one-two punch for employers.

Physicians’ Education Resource® (PER®), a worldwide leading resource for continuing medical education (CME), will conduct the CME-Certified satellite symposium Improving Outcomes in Progressive Fibrosing-Interstitial Lung Disease (PF-ILD) Through Early and Accurate Diagnosis, adjunct to the 2019 American Roentgen Ray Society (ARRS) Annual Meeting.

Echelon a leader in indoor cycling and innovative fitness technology, will hold a free Worship Ride on Sunday, April 28th. Filmed in the Bible Belt, Chattanooga, TN and streamed live across the world, the class will invigorate both the body and spirit in a 45-minute ride that features a high-energy workout, praise music and spiritual guidance.

The increase was announced this morning at the Annual Meeting of Shareholders in New Brunswick, N.J.

Canadians want access to the latest treatments for themselves, and their friends and family, especially for diseases and conditions where limited options are available.

N8 Medical, LLC (N8 Medical) today announced its first-in-human clinical trials of its flagship CeraShield™ endotracheal tube (CeraShield™ ETT) for intensive care unit patients expected to require mechanical ventilation for more than 48 hours

According to Pew Research, more than 70 percent of teens feel anxiety and depression are problems among their peers.

Pinnacle Treatment Centers (PTC), a leader in providing accessible treatment for adult men and women struggling with substance use disorders, has opened Vineland Treatment Services, located at 1051 W. Sherman Ave, Suite 4B, in Vineland, New Jersey.

Better data will help turn the tide against Nigeria’s most deadly killer, malaria, which escapes diagnosis and treatment at a large scale partly due to inefficiencies within the nation’s medicine-and-supplies tracking systems.

Xcision Medical Systems, LLC announced that the GammaPod stereotactic radiotherapy system has received CE marking, paving the way for new sales in Europe and offering patients the latest option in noninvasive breast cancer treatment.